Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179. - Wikidata - wikimedia - TriplyDB

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

http://www.wikidata.org/entity/Q43966251

about

Endothelial dysfunction in young patients with acute ST-elevation myocardial infarction.Inflammation aggravates disease severity in Marfan syndrome patients.Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.LIFE and SCOPE: what guidance do they offer alongside ALLHAT and ANBP2?Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension?Ramipril and Losartan Exert a Similar Long-Term Effect upon Markers of Heart Failure, Endogenous Fibrinolysis, and Platelet Aggregation in Survivors of ST-Elevation Myocardial Infarction: A Single Centre Randomized Trial.Targeting platelets for prevention and treatment of cardiovascular disease.Losartan in cardiovascular disease.Mechanisms underlying the cardiac antifibrotic effects of losartan metabolites.Review: angiotensin II type 1 receptor blockers: class effects versus molecular effects Diabetic microvascular complications: possible targets for improved macrovascular outcomes Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke.Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1.A small difference in the molecular structure of angiotensin II receptor blockers induces AT₁ receptor-dependent and -independent beneficial effects.Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis.Telmisartan, an angiotensin-II receptor blocker ameliorates cardiac remodeling in rats with dilated cardiomyopathy.Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage.Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study.High-salt intake induces cardiomyocyte hypertrophy in rats in response to local angiotensin II type 1 receptor activation.Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.Investigation of the effect of telmisartan on experimentally induced peripheral nerve injury in rats.Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.Vitamin D protection from rat diabetic nephropathy is partly mediated through Klotho expression and renin-angiotensin inhibition.The angiotensin II receptor antagonist, losartan, enhances regulator of G protein signaling 2 mRNA expression in vascular smooth muscle cells of Wistar rats.Hemodynamic effects of vasorelaxant compounds in mice lacking one, two or all three angiotensin II receptors.Proinflammatory role for AT1 receptors in the rat synovium.

P2860

Q33719624-5E0FEFEF-1C10-44B3-822A-5E3E12F34AC0 Q34221265-F4D5C869-DA6B-4B24-BE79-9AF5075E197E Q35171866-6DEABC17-2CA9-4B41-8E3F-CB17554EF92D Q35636620-C360120C-51E7-48F6-91D2-3E787A0CC703 Q36223165-AF5EF3C3-435A-4214-AC88-55BDE12819B4 Q36737718-AD56E620-0273-4199-94AB-A27D93A16949 Q37004721-B2763766-5EE5-4CAA-8BF1-BA1A1739B453 Q37608510-185F1C05-A5CE-4692-AFC7-69055BE455BB Q37623540-D87D960C-EF15-49EE-8806-0690A681C3A7 Q37770171-36301F16-E31C-4C02-9FC5-EB1E60613A2F Q37892915-C1DDA5C4-16A0-48C6-99B3-37DEFFAAF7AC Q38867733-808D2A78-9F10-4D70-A4F4-1406894C6162 Q39623328-C554E6BC-E7AA-4F84-80C1-988487996649 Q39674136-629C636C-B5C3-45C1-867E-38EEA36B4E19 Q42650194-406E402E-E97F-48E3-8ECB-0E180DB77349 Q43036719-E6D8426A-8213-428B-9C62-54899EC5FCEA Q43134828-0B7FE59F-E70F-4096-9171-A23CA78C6F13 Q43416129-55E26F6D-82EA-40CC-8FC8-CE593169EA3F Q43559972-BAE0AD7D-6936-422B-A3CD-9BFAF8A1C34E Q44855214-29E7C21D-4F8D-42A7-A4B0-10A2DF708F3E Q46188427-0902A06F-AF35-4EDA-90AF-4088D73CEBE4 Q46382805-4489421A-CEA1-4897-ACE1-D93F19DA4838 Q46477791-2BA50B27-B5F6-4ECB-B414-56FE00AFDC83 Q47225498-29CD3863-51A8-4692-A27B-9C42C4670ACC Q50892340-6A36A3CD-BF9D-477D-A677-40543914C05C Q54256113-B231189E-D319-4DC7-9FA6-50009F793DD2 Q55408555-5F9EB0C7-37B8-4E22-A609-4D263AD0373A

P2860

Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179.

http://www.wikidata.org/entity/Q43966251

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Angiotensin II receptor-indepe ...... the active metabolite EXP3179.

@en

Angiotensin II receptor-indepe ...... the active metabolite EXP3179.

@nl

type

label

Angiotensin II receptor-indepe ...... the active metabolite EXP3179.

@en

Angiotensin II receptor-indepe ...... the active metabolite EXP3179.

@nl

prefLabel

Angiotensin II receptor-indepe ...... the active metabolite EXP3179.

@en

Angiotensin II receptor-indepe ...... the active metabolite EXP3179.

@nl

P1433

Q43966251-6D8E20EF-2BCA-48D2-9F00-846FE60E96CA

P1476

Q43966251-060339D7-EF59-42F8-B3FD-B9482D0DBEA6

P2093

Q43966251-14B0EB18-51F4-4CBB-893E-6CFD816FEF5A

Q43966251-21E5B266-750E-4A75-A857-C95A36A692FF

Q43966251-4651E40D-FD58-49D0-B972-153C3F39AA3C

Q43966251-6B3D8BA4-B89B-44B3-B415-F3E1EDC51763

Q43966251-702E1BDE-3DC4-4F20-985D-6A3E5A137E6E

Q43966251-86864533-A055-4554-87BF-1277F855DAF1

Q43966251-873BC056-0D5B-4126-8E70-EEA3BF3B1AD3

Q43966251-A768CB8D-40A6-4F68-A40D-516F26CBE9F0

Q43966251-C149283E-E853-4AF2-85E8-69EA3027A028

Q43966251-D0F5014B-01D4-490C-AFBC-EAFE888AC92C

P304

Q43966251-2F1F1500-94C9-45BA-8489-C368CB3EB7E5

P31

Q43966251-96FE1620-422B-457F-9498-FFD731DF5225

P356

Q43966251-8D9BF966-52B1-4EE8-90D9-AADD71EB12E6

P433

Q43966251-0183D391-A0C1-4767-A3F1-D0C10092318C

P478

Q43966251-12B77B06-5376-437D-8AE2-354577B5B18B

P50

Q43966251-174F2E53-661A-45C0-B486-6563AEA3DCF8

P577

Q43966251-45962E1B-52AC-451A-A4B2-7615CD668783

P698

Q43966251-3E2301B5-DC1C-4F74-9ED8-B79488C4DF0B

P356

01.RES.0000014434.48463.35

P1433

Circulation Research

P1476

Angiotensin II receptor-indepe ...... the active metabolite EXP3179

@en

P2093

Bernhard Schieffer

http://www.w3.org/2001/XMLSchema#string

Christine Krämer

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tsikas

http://www.w3.org/2001/XMLSchema#string

Helmut Drexler

http://www.w3.org/2001/XMLSchema#string

Jana Witte

http://www.w3.org/2001/XMLSchema#string

Julia Sunkomat

http://www.w3.org/2001/XMLSchema#string

Maren Luchtefeld

http://www.w3.org/2001/XMLSchema#string

Michael Walden

http://www.w3.org/2001/XMLSchema#string

Rainer H Böger

http://www.w3.org/2001/XMLSchema#string

Wolf-Georg Forssmann

http://www.w3.org/2001/XMLSchema#string

P304

770-776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.0000014434.48463.35

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11964369

http://www.w3.org/2001/XMLSchema#string